This is one of the first questions people ask us, and it deserves a straight answer. The honest version is: it depends on where you are in treatment, what condition you’re treating, and what you do alongside the infusions. But we can be more specific than that, because the research has gotten considerably more detailed over the past few years.
We’ll walk through the timeline from a single infusion through a full treatment course and into maintenance, cite the studies that inform how we think about duration, and cover the factors that influence how long your results are likely to hold.
A Single Infusion: What the Data Shows
Let’s start with the most basic unit of ketamine treatment: one IV infusion. The pharmacology here is well-studied. Antidepressant effects typically begin within about 40 minutes of the infusion starting. They tend to peak around 24 hours post-infusion, when patients often report the most noticeable shift in mood and cognitive flexibility.
From that peak, the effects of a single infusion generally last 3 to 7 days. This isn’t guesswork. Meta-analyses pooling data from multiple randomized controlled trials show that a single ketamine dose maintains statistical superiority over placebo for roughly 10 to 12 days before the difference fades. For most patients, the subjective experience of improvement starts tapering somewhere in that first week.
This is useful to understand because it explains why we don’t treat with single infusions and call it done. A week of relief matters, especially for someone in crisis. But it’s not a treatment plan. It’s a proof of concept that your biology responds to ketamine, and it’s the starting point for building something more lasting.
A Full Treatment Course: Stacking the Effect
The standard initial protocol at most ketamine clinics, including ours, involves six infusions delivered over two to three weeks. The reasoning behind this isn’t arbitrary. A randomized controlled trial published in the American Journal of Psychiatry demonstrated that twice-weekly infusions over three weeks produce more sustained therapeutic effects than a single infusion alone. Each session appears to build on the one before it, deepening the neuroplastic changes that underlie the clinical improvement.
Think of it this way: a single infusion opens a window. The neuroplastic window is the period after each infusion when your brain is more receptive to forming new neural connections and patterns. A series of infusions keeps that window open longer and allows the new patterns to consolidate more firmly. We go into this mechanism in detail in our article on the neuroplastic window, but the short version is that repeated exposure gives the brain more opportunity to rewire away from the depressive default.
A 2025 Cleveland Clinic study followed more than 1,000 patients through a full course of ketamine treatment and found improvements in pain interference, depression scores, and physical function lasting up to six months. That’s a meaningful duration, and it’s worth noting that the study looked at real-world clinical patients rather than a tightly controlled trial population. These were people with complex histories, comorbidities, and varying baseline severity. For a more detailed look at what a full series involves, see our article on how many ketamine sessions to expect.
Maintenance: Keeping the Benefits Going
For many patients, the initial course produces a significant response, but the question becomes how to sustain it. This is where maintenance infusions come in. Research published in the American Journal of Psychiatry supports the use of maintenance dosing, typically about once a month, as a strategy for extending the benefits of the initial treatment course.
We’ve written a detailed guide to ketamine maintenance protocols that covers the specifics of how we approach this. The general principle is that maintenance infusions are spaced based on how long each patient’s response holds. Some people do well at four-week intervals. Others find they can stretch to six or eight weeks over time. A smaller number eventually discontinue maintenance altogether because the changes have held on their own.
The trajectory isn’t always linear. Some patients need closer spacing initially after their series, then gradually extend the intervals as their response stabilizes. We adjust based on how you’re actually doing, not on a rigid calendar.
New Research on Extending Duration
One of the most interesting recent findings in ketamine research addresses duration directly. A 2025 study from Vanderbilt University, published in Science, demonstrated that it is feasible to extend a single ketamine dose’s efficacy from approximately one week to up to two months. The researchers identified mechanisms that could be targeted to prolong the antidepressant effect without requiring additional doses during that period.
This is significant because the short duration of a single infusion has always been one of the practical limitations of ketamine therapy. If that window can be reliably extended, it changes the treatment burden considerably. The Vanderbilt work is still in relatively early stages of clinical translation, but the principle it establishes is important: the duration of ketamine’s effect is not fixed. It can be modified.
Separately, systematic reviews from 2025 and 2026 have examined the effect of combining ketamine with structured psychotherapy. The findings suggest that engaging in therapy during the neuroplastic window following each infusion may enhance and extend the therapeutic response. The rationale is intuitive: if ketamine creates a period of heightened neuroplasticity, doing focused therapeutic work during that period may help consolidate the psychological and behavioral changes that make the improvement stick.
This is one of the reasons we encourage patients to have a therapist involved in their treatment process, and why we discuss integration strategies as part of our care. For more on what the days and weeks after treatment look like, see our article on what happens after ketamine therapy.
What Factors Affect How Long Your Results Last
Individual variation in treatment duration is real, and it’s driven by identifiable factors. Here are the main ones we see clinically, supported by the research literature:
- Severity and chronicity of your condition. Patients with longer histories of treatment-resistant depression or chronic pain often need more infusions to reach a stable response, and may need more frequent maintenance. This isn’t a failure of treatment. It reflects the depth of the neural patterns being addressed.
- Metabolic differences. People metabolize ketamine at different rates. Variations in liver enzyme activity, body composition, and other pharmacokinetic factors influence how quickly the drug is cleared from your system and, to some degree, how long the downstream effects persist.
- Concurrent psychotherapy. As noted above, evidence increasingly suggests that combining ketamine with structured therapy during the neuroplastic window can extend the duration of benefit. Patients who are actively engaged in therapy alongside their infusions tend to report longer-lasting improvements.
- Lifestyle factors. Sleep quality, physical activity, nutrition, stress management, and social connection all influence how well therapeutic gains hold. None of these are substitutes for treatment, but they create a more favorable environment for the neuroplastic changes to persist.
- Maintenance protocol adherence. Patients who follow through with a thoughtful maintenance schedule tend to sustain their results more reliably than those who stop after the initial series and wait to see what happens. This is consistent with the American Journal of Psychiatry data supporting ongoing dosing.
A Realistic Timeline
Putting this all together, here is a realistic timeline for what most patients can expect:
- First infusion: Effects begin within about 40 minutes. Peak improvement around 24 hours. Duration of 3 to 7 days.
- Initial series (6 infusions over 2-3 weeks): Cumulative improvement builds across sessions. Most patients report a more stable and pronounced response by the fourth to sixth infusion.
- Post-series period (weeks 4-12): The gains from the initial series typically hold for several weeks to a few months. This is the period when we assess whether and how often maintenance infusions are needed.
- Maintenance phase: Monthly infusions (or at the interval that works for you) to sustain the response. Some patients gradually extend the interval over time.
- Long-term outlook: The Cleveland Clinic data shows improvements holding up to six months with a full course. With maintenance and concurrent therapy, many patients sustain meaningful improvement indefinitely.
We want to be careful here not to overpromise. Not every patient reaches six months of sustained improvement. Not every patient responds equally to the initial series. The data gives us a range, and your specific trajectory will depend on the factors outlined above. What we can say is that the research supports a treatment model that, for many people, produces durable results when approached thoughtfully.
Researchers demonstrated that it is feasible to extend a single ketamine dose’s efficacy from approximately one week to up to two months, establishing that the duration of ketamine’s antidepressant effect is modifiable rather than fixed. — Science, 2025 (Vanderbilt University)
The Cost Consideration
Duration inevitably connects to cost. A treatment that lasts longer between sessions costs less over time. We’re transparent about our pricing and the financial realities of ketamine therapy. For a full breakdown, including what the initial series and maintenance infusions cost, see our ketamine therapy cost guide. We also discuss HSA/FSA eligibility and other ways patients manage the financial side of ongoing treatment.